[Pharmacology of a new neuroleptic agent, 1-(4-oxyphenyl)-2n-butylamino-ethanone hydrochloride (BON)].
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003371:Cough / Q000188:drug therapy; D004231:Diuresis / Q000187:drug effects; D004569:Electroencephalography; D004983:Ethanolamines / Q000494:pharmacology*; D005725:Ganglia, Autonomic / Q000187:drug effects; D006973:Hypertension / Q000188:drug therapy; D006977:Hypertension, Renal / Q000188:drug therapy; D007659:Ketones / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010146:Pain / Q000188:drug therapy; D012018:Reflex / Q000187:drug effects; D012640:Seizures / Q000188:drug therapy; D013127:Spinal Nerves / Q000187:drug effects; D013312:Stress, Physiological / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000494:pharmacology
D004983:Ethanolamines; D007659:Ketones; D014149:Tranquilizing Agents
Zur Pharmakologie eines neuen Neuroplegicums, 1-(4-Oxyphenyl)-2n-butylamino-aethanon-hydrochlorid (BON)